Aimei Health Technology Co. Ltd. Secures $150,000 Promissory Note Extension for Business Combination with United Hydrogen
Aimei Health Technology Co. Ltd. has announced an amendment to its existing financial arrangements by securing an unsecured promissory note amounting to $150,000. The agreement, dated September 5, 2025, involves Aimei Health Ltd and United Hydrogen Group Inc., both exempted companies incorporated in the Cayman Islands, as equal contributors to the loan. This financing allows Aimei Health Technology to extend the deadline for completing its initial business combination to October 6, 2025. The promissory note, which bears no interest, is set to mature upon the successful consummation of a business combination with United Hydrogen. Additionally, the lenders have the option to convert the note into private units of Aimei Health Technology, offering flexibility in the agreement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aimei Health Technology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-012726), on September 05, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。